医药网9月9日讯 血管紧张素转换酶抑制剂（ACEI，简称普利类）、钙拮抗剂（CCB）、血管紧张素Ⅱ受体拮抗剂（ARB，沙坦类）和β阻滞剂是全球高血压药物治疗市场的主力品种。近五年来，新一代抗高血压药...
On September 9, ACEI, CCB, ARB and beta blockers are the main products in the global hypertensive drug market. In the past five years, a new generation of antihypertensive drugs has been developed.
